Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Cott Corporation (USA) (COT) A Good Stock To Buy?

Page 1 of 2

Many investors, including Carl Icahn or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest rate environment that leads to companies swapping their equity for debt and focusing mostly on short-term performance such as beating the quarterly earnings estimates. In the third quarter, many investors lost money due to unpredictable events such as the concerns over Valeant’s drug pricing policy that led to an overall drop among pharma stocks. Nevertheless, many of the stocks that tanked in the third quarter still sport strong fundamentals and their decline was more related to the general market sentiment rather than their individual performance and hedge funds kept their bullish stance. In this article we will find out how hedge fund sentiment to Cott Corporation (USA) (NYSE:COT) changed recently.

Is Cott Corporation (USA) a good investment now? Money managers are in a bullish mood. The number of long hedge fund positions rose by 4 in recent months. COT was in 23 hedge funds’ portfolios at the end of September. There were 19 hedge funds in our database with COT holdings at the end of the previous quarter. At the end of this article we will also compare COT to other stocks including Finisar Corporation (NASDAQ:FNSR), TriNet Group Inc (NYSE:TNET), and Ramco-Gershenson Properties Trust (NYSE:RPT) to get a better sense of its popularity.

Follow Cott Corp (NYSE:COT)
Trade (NYSE:COT) Now!

Keeping this in mind, let’s take a glance at the latest action surrounding Cott Corporation (USA) (NYSE:COT).

How have hedgies been trading Cott Corporation (USA) (NYSE:COT)?

At Q3’s end, a total of 23 of the hedge funds tracked by Insider Monkey were long this stock, a change of 21% from the second quarter. With hedge funds’ capital changing hands, there exists a few noteworthy hedge fund managers who were upping their stakes considerably (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, John A. Levin’s Levin Capital Strategies has the biggest position in Cott Corporation (USA) (NYSE:COT), worth close to $147.3 million, corresponding to 2.5% of its total 13F portfolio. On Levin Capital Strategies’s heels is Renaissance Technologies, led by Jim Simons, holding a $29.7 million position; 0.1% of its 13F portfolio is allocated to the company. Some other members of the smart money that hold long positions include D E Shaw, Phill Gross and Robert Atchinson’s Adage Capital Management and Peter S. Park’s Park West Asset Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!